Hema.to raises €3.6M Seed round

27 February 2025· Munich, Germany· health, diagnostics, ai, biotech, b2b, pure_software

The newly raised funds will be used to refine product-market-fit in blood cancer diagnostics, pursue additional European certification, conduct clinical studies, and scale commercial deployment.

Investors

LeadLUMO Labs

Also participating

High-Tech GründerfondsBayern KapitalElaia PartnersHeal Capital

About Hema.to

Stage

Seed

Headquarters

Munich, Germany

Founded

2021

Team Size

21–50

Sectors

healthdiagnosticsaibiotechb2bpure_software

http://hema.to/

Source: https://siliconcanals.com/crowdfunding/hema-to-raises-3-6m/